Physician
Ophthalmology
Dr. Frederick L. Ferris III, MD
|
|
Give Review
Frederick Ferris works in the field of Ophthalmology. He went to medical school at Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is one of the top medical schools in the US. Johns Hopkins University School of Medicine is ranked 3/29 in Research/PrimaryCare. He received awards:"Fellow (FAAO)". Dr. Frederick L. Ferris III is a published doctor and has 64 publications published. The lastest was: 'A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular Edema.'
Publications
- Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema.
- Longitudinal Study of Age-Related Cataract Using Dynamic Light Scattering: Loss of α-Crystallin Leads to Nuclear Cataract Development.
- A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular Edema.
- Changes in Lens Opacities on the Age-Related Eye Disease Study Grading Scale Predict Progression to Cataract Surgery and Vision Loss: Age-Related Eye Disease Study Rep...
- Effect of ranibizumab on high-speed indocyanine green angiography and minimum intensity projection optical coherence tomography findings in neovascular age-related mac...
- Intravitreal Sirolimus for the Treatment of Geographic Atrophy: Results of a Phase I/II Clinical Trial.
- Outcomes of Eyes with Lesions Composed of >50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).
- Immune Responses in Age-Related Macular Degeneration and a Possible Long-term Therapeutic Strategy for Prevention.
- Secondary Analyses of the Effects of Lutein/Zeaxanthin on Age-Related Macular Degeneration Progression: AREDS2 Report No. 3.
- Ten-Year Follow-up of Age-Related Macular Degeneration in the Age-Related Eye Disease Study: AREDS Report No. 36.
- Lutein/Zeaxanthin for the Treatment of Age-Related Cataract: AREDS2 Randomized Trial Report No. 4.
- Evaluation of Optimized Digital Fundus Reflex Photographs for Lens Opacities in the Age-Related Eye Disease Study 2. AREDS2 Report 7.
- Web-based versus Paper Administration of Common Ophthalmic Questionnaires: Comparison of Subscale Scores.
- Subconjunctival Palomid 529 in the treatment of neovascular age-related macular degeneration.
- Methods and Reproducibility of Grading Optimized Digital Color Fundus Photographs in the Age-Related Eye Disease Study 2 (AREDS2)(AREDS2 Report Number 2).
- Ten-Year Incidence Rates of Age-Related Cataract in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 33.
- Clinical Classification of Age-Related Macular Degeneration.
- Hypomethylation of the IL17RC Promoter Associates with Age-Related Macular Degeneration.
- Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment: Three-Year Randomized Trial Results.
- The Age-Related Eye Disease Study 2 (AREDS2): Study Design and Baseline Characteristics (AREDS2 Report Number 1).
- Panretinal photocoagulation for proliferative diabetic retinopathy.
- Risk Assessment Model for Development of Advanced Age-Related Macular Degeneration.
- Prevalence of posterior subcapsular cataracts in volunteer cytapheresis donors.
- Changes in retinal sensitivity in geographic atrophy progression as measured by microperimetry.
- Copy number variations in candidate genes in neovascular age-related macular degeneration.
- Treatment of geographic atrophy by the topical administration of OT-551: results of a phase II clinical trial.
- Use of patient-reported outcomes in medical product development: a report from the 2009 NEI/FDA Clinical Trial Endpoints Symposium.
- Arnall Patz, MD: The Spirit of Collaboration.
- Evaluation of the age-related eye disease study clinical lens grading system AREDS report No. 31.
- Factors associated with visual acuity outcomes after vitrectomy for diabetic macular edema: diabetic retinopathy clinical research network.
- Progression of geographic atrophy and genotype in age-related macular degeneration.
- Preliminary assessment of celecoxib and microdiode pulse laser treatment of diabetic macular edema.
- Relationship between photoreceptor outer segment length and visual acuity in diabetic macular edema.
- Toll-like receptor polymorphisms and age-related macular degeneration: replication in three case-control samples.
- Increased prevalence of myopia in the United States between 1971-1972 and 1999-2004.
- Risk of advanced age-related macular degeneration after cataract surgery in the Age-Related Eye Disease Study: AREDS report 25.
- Clinical trials - more than an assessment of treatment effect: LXV Edward Jackson Memorial Lecture.
- Clinical detection of precataractous lens protein changes using dynamic light scattering.
- The HtrA1 promoter polymorphism, smoking, and age-related macular degeneration in multiple case-control samples.
- Oral supplementation of lutein/zeaxanthin and omega-3 long chain polyunsaturated fatty acids in persons aged 60 years or older, with or without AMD.
- Prevalence of refractive error in the United States, 1999-2004.
- Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium.
- An electronic medical records system for clinical research and the EMR EDC interface.
- Visual acuity as an outcome measure in clinical trials of retinal diseases.
- The LOC387715 polymorphism and age-related macular degeneration: replication in three case-control samples.
- Intravitreal anti-vascular endothelial growth factor therapy with pegaptanib for advanced von Hippel-Lindau disease of the retina.
- Dose-ranging study of lutein supplementation in persons aged 60 years or older.
- The effect of lutein and zeaxanthin supplementation on metabolites of these carotenoids in the serum of persons aged 60 or older.
- Anatomical and visual results of vitreoretinal surgery for stage 5 retinopathy of prematurity.
- Vitamin E in the treatment of uveitis-associated macular edema.
- Serum inflammatory markers in diabetic retinopathy.
- Central visual function and the NEI-VFQ-25 near and distance activities subscale scores in people with type 1 and 2 diabetes.
- Complement factor H polymorphism in age-related macular degeneration.
- A new treatment for ocular neovascularization.
- Diabetic retinopathy.
- Blindness and visual impairment: a public health issue for the future as well as today.
- Histopathology and regression of retinal hard exudates in diabetic retinopathy after reduction of elevated serum lipid levels.
- The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study.
- Who should receive oral supplement treatment for age-related macular degeneration?
- A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol.
- Foreword: Evaluation of new treatment paradigms for diabetic retinopathy and macular edema.
- Prevalence of anti-retinal autoantibodies in different stages of Age-related macular degeneration.
- Green or yellow laser treatment for diabetic macular edema: exploratory assessment within the Diabetic Retinopathy Clinical Research Network.
Schools
Johns Hopkins University School of Medicine
Doctors Specialties
- Ophthalmology
Accepted Insurances
Awards
- Fellow (FAAO)
Education
-
Johns Hopkins University -
Johns Hopkins University School of Medicine
Helpful Reviews
Similar Doctors
|
|
Monica D. Dalal
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Swati Singh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael D. Duplessie, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan C. Javitt, MD |
|
|
Dr. Paul A. Sieving, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Robert B. Nussenblatt, MD |
|
|
Dr. Richard D. Stutzman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George A. Patterson III, MD
This Doctor is OpenDoctor Recommended.
|